[SCHEDULE 13G] EyePoint, Inc. Passive Investment Disclosure (>5%)
EyePoint: Janus Henderson reports 10.9% stake
EyePoint, Inc. (EYPT) reports that Janus Henderson Group Ltd., through its investment adviser subsidiaries, is deemed the beneficial owner of 9,366,332 shares of common stock, representing 10.9% of the class, as of August 31, 2026.
EyePoint, Inc. (EYPT) reports that Janus Henderson Group Ltd., through its investment adviser subsidiaries, is deemed the beneficial owner of 9,366,332 shares of common stock, representing 10.9% of the class, as of August 31, 2026. All of these shares are held in client accounts of various Janus Henderson asset managers, which exercise investment and/or voting discretion and therefore may be deemed to share voting and dispositive power over the position.
The asset managers disclaim rights to receive dividends or sale proceeds, which instead accrue to the underlying managed portfolios. Among these, Janus Henderson Biotech Innovation Master Fund Ltd. alone has rights to dividends or proceeds relating to more than five percent of EyePoint’s common stock. Janus Henderson Group Ltd. files on Schedule 13G as a parent holding company with no sole voting or dispositive power over EyePoint shares.
Positive
None.
Negative
None.
Key Figures
Beneficial ownership shares:9,366,332 sharesPercent of class:10.9%Shared voting power:9,366,332 shares+4 more
7 metrics
Beneficial ownership shares9,366,332 sharesCommon stock of EyePoint, Inc. beneficially owned as of August 31, 2026
Percent of class10.9%Portion of EyePoint, Inc. common stock class reported as beneficially owned
Shared voting power9,366,332 sharesShares over which Janus Henderson has shared power to vote or direct the vote
Shared dispositive power9,366,332 sharesShares over which Janus Henderson has shared power to dispose or direct disposition
Sole voting power0 sharesEyePoint, Inc. shares with sole voting power reported by Janus Henderson
Sole dispositive power0 sharesEyePoint, Inc. shares with sole dispositive power reported by Janus Henderson
Filing dateSeptember 8, 2026Date signed by Head of North America Compliance
Key Terms
beneficial owner, Schedule 13G, Managed Portfolios, dispositive power, +2 more
6 terms
beneficial ownerregulatory
"may be deemed to be the beneficial owner of 9,366,332 common stock"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
Schedule 13Gregulatory
"has filed this schedule pursuant to 13g as a parent holding company"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Managed Portfoliosfinancial
"collectively referred to herein as Managed Portfolios"
dispositive powerregulatory
"Shared Dispositive Power 9,366,332.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Power of Attorneyregulatory
"Exhibit 24: Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
irrevocable delegationregulatory
"Due to an irrevocable delegation of investment and voting discretion"
FAQ
How many EYPT shares does Janus Henderson Group Ltd. report owning?
Janus Henderson Group Ltd. is deemed the beneficial owner of 9,366,332 shares of EyePoint, Inc. common stock, held across client accounts managed by its asset management subsidiaries that exercise investment and/or voting discretion.
What percentage of EyePoint, Inc. (EYPT) does Janus Henderson’s holding represent?
The reported position represents 10.9% of EyePoint, Inc. common stock. This entire percentage is associated with shares over which Janus Henderson’s asset managers share voting and dispositive power on behalf of their clients.
Does Janus Henderson have sole voting or dispositive power over EYPT shares?
No. Janus Henderson reports 0 shares with sole voting or dispositive power and 9,366,332 shares with shared voting and shared dispositive power, reflecting authority exercised through its asset management subsidiaries.
Who receives dividends and sale proceeds from the EYPT shares managed by Janus Henderson?
The Managed Portfolios—the underlying client accounts—have the right to receive all dividends and sale proceeds from the EyePoint, Inc. shares. The asset managers disclaim ownership of those economic rights.
Which Janus Henderson fund holds more than 5% of EyePoint, Inc.?
Among the managed portfolios, only Janus Henderson Biotech Innovation Master Fund Ltd. has the right to receive dividends or sale proceeds from more than five percent of EyePoint, Inc. common stock, subject to an irrevocable delegation of investment and voting discretion.
What type of SEC filing did Janus Henderson submit for its EYPT position?
Janus Henderson Group Ltd. reported its EyePoint, Inc. holdings on Schedule 13G as a parent holding company, indicating a passive beneficial ownership position rather than an activist Schedule 13D filing.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
EYEPOINT, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
30233G209
(CUSIP Number)
08/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
30233G209
1
Names of Reporting Persons
JANUS HENDERSON GROUP Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
JERSEY
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
9,366,332.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
9,366,332.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,366,332.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.9 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
EYEPOINT, INC.
(b)
Address of issuer's principal executive offices:
480 PLEASANT STREET, SUITE C400
WATERTOWN, MA 02472
Item 2.
(a)
Name of person filing:
Janus Henderson Group Ltd.
In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Janus Henderson Group Ltd. It does not include securities, if any, beneficially owned by Janus Henderson Group Ltd.s ultimate parent Jupiter Topco LLC, the direct or indirect owners of Jupiter Topco LLC, or other persons that may be deemed under control of such owners. Any beneficial ownership by such persons has been disaggregated from that of Janus Henderson Group Ltd. in accordance with the release.
(b)
Address or principal business office or, if none, residence:
201 Bishopsgate
EC2M 3AE, United Kingdom
(c)
Citizenship:
Y9
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
30233G209
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Janus Henderson Group Ltd. (JHG) is the ultimate parent of a number of SEC-registered investment advisers and foreign equivalents thereof, including but not limited to Janus Henderson Investors US LLC, Janus Henderson Investors UK Limited, Janus Henderson Investors Australia Institutional Funds Management Limited, Janus Henderson Investors Middle East Limited, Janus Henderson Investors (Jersey) Limited, Janus Henderson Investors (Japan) Limited, Janus Henderson Investors (Singapore) Limited, Kapstream Capital Pty Limited, Privacore Capital Advisors LLC, Tabula Investment Management Limited, Victory Park Capital Advisors LLC, and Richard Berstein Advisors LLC (each, an Asset Manager and together, the Asset Managers). The Asset Managers generally exercise investment and/or voting discretion on behalf of their clients which include investment companies, other investment advisers, institutional separate accounts and retail separate accounts (collectively referred to herein as Managed Portfolios).
As a result of their exercise of investment and/or voting discretion on behalf of the Managed Portfolios, the Asset Managers may be deemed to be the beneficial owner of 9,366,332 common stock of Eyepoint, Inc. However, the Asset Managers do not have the right to receive any dividends from, or the proceeds from the sale of, the securities held in the Managed Portfolios and disclaim any ownership associated with such rights.
(b)
Percent of class:
10.9 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
9366332
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
9366332
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The Managed Portfolios have the right to receive all dividends from, and the proceeds from the sale of, the securities held in their respective accounts.
Of the Managed Portfolios, only the Janus Henderson Biotech Innovation Master Fund Ltd. has the right to receive dividends from, or the proceeds from the sale of, more than five percent of the common stock of Eyepoint, Inc. Due to an irrevocable delegation of investment and voting discretion to an Asset Manager on less than 60 days notice, the Fund is not considered a Reporting Person under Section 13(d) and (g).
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please refer to Exhibit 99.
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
N/A
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
N/A
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
